b'<?xml version="1.0" encoding="utf-8"?>\n<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">\n<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">\n    \n    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />\n        <!-- AppResources meta begin -->\n        <script type="text/javascript">var ncbi_startTime = new Date();</script>\n        <!-- AppResources meta end -->\n        \n        <!-- TemplateResources meta begin -->\n        <meta name="paf_template" content="" />\n\n        <!-- TemplateResources meta end -->\n        \n        <!-- Logger begin -->\n        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="nihpa" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC2834826/" /><meta name="ncbi_app" content="pmc" />\n        <!-- Logger end -->\n        \n        <title>A VLP vaccine for epidemic Chikungunya virus protects non-human primates against infection</title>\n        \n        <!-- AppResources external_resources begin -->\n        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>\n\n        <!-- AppResources external_resources end -->\n        \n        <!-- Page meta begin -->\n        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834826/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Nature medicine" /><meta name="citation_title" content="A VLP vaccine for epidemic Chikungunya virus protects non-human primates against infection" /><meta name="citation_authors" content="Wataru Akahata, Zhi-yong Yang, Hanne Andersen, Siyang Sun, Heather A. Holdaway, Wing-Pui Kong, Mark G. Lewis, Stephen Higgs, Michael G. Rossmann, Srinivas Rao, Gary J. Nabel" /><meta name="citation_date" content="March 2010" /><meta name="citation_issue" content="3" /><meta name="citation_volume" content="16" /><meta name="citation_firstpage" content="334" /><meta name="citation_doi" content="10.1038/nm.2105" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC2834826/?report=abstract" /><meta name="citation_pmid" content="20111039" /><meta name="DC.Title" content="A VLP vaccine for epidemic Chikungunya virus protects non-human primates against infection" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="NIH Public Access" /><meta name="DC.Contributor" content="Wataru Akahata" /><meta name="DC.Contributor" content="Zhi-yong Yang" /><meta name="DC.Contributor" content="Hanne Andersen" /><meta name="DC.Contributor" content="Siyang Sun" /><meta name="DC.Contributor" content="Heather A. Holdaway" /><meta name="DC.Contributor" content="Wing-Pui Kong" /><meta name="DC.Contributor" content="Mark G. Lewis" /><meta name="DC.Contributor" content="Stephen Higgs" /><meta name="DC.Contributor" content="Michael G. Rossmann" /><meta name="DC.Contributor" content="Srinivas Rao" /><meta name="DC.Contributor" content="Gary J. Nabel" /><meta name="DC.Date" content="2010 Mar" /><meta name="DC.Identifier" content="10.1038/nm.2105" /><meta name="DC.Language" content="en" /><meta property="og:title" content="A VLP vaccine for epidemic Chikungunya virus protects non-human primates against infection" /><meta property="og:type" content="article" /><meta property="og:description" content="Chikungunya virus (CHIKV) has infected millions of people in Africa, Europe, and Asia, since its re-emergence in Kenya in 2004. The severity of disease and spread of this epidemic virus present a serious public health threat in the absence of vaccines ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834826/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><meta name="ncbi_feature" content="associated_data" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:\'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/\'" /><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-hhspa.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">\n        div.pmc_para_cit li.highlight,\n        div.pmc_para_cit li.highlight .one_line_source\n        { background: #E0E0E0; }\n        a.bibr.highlight { background: #E0E0E0; } \n      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC2834826/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC2834826/pdf/nihms-172047.pdf" />\n\n        <!-- Page meta end -->\n    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="8A1BC6A5E9A463610000000002CB02CB.m_8" />\n<meta name=\'referrer\' content=\'origin-when-cross-origin\'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>\n    <body class="article">\n        <div class="grid">\n            <div class="col twelve_col nomargin shadow">\n                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->\n                <div class="sysmessages">\n                    <noscript>\n\t<p class="nojs">\n\t<strong>Warning:</strong>\n\tThe NCBI web site requires JavaScript to function. \n\t<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>\n\t</p>\n\t</noscript>\n                </div>\n                <!--/.sysmessage-->\n                <div class="wrap">\n                    <div class="page">\n                        <div class="top">\n                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main\n                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to\n                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>\n                            <div class="header">\n    <div class="res_logo">\n  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>\n  <div class="NLMLogo">\n    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>\n    <br />\n    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>\n  </div>\n</div>\n    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:\'pmc-search-autocomplete\',disableUrl:\'NcbiSearchBarAutoComplCtrl\'" autocomplete="off" data-sbconfig="ds:\'no\',pjs:\'no\',afs:\'yes\'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>\n                        <a href="/pmc/advanced/">Advanced</a>\n                    </li><li>\n                        <a href="/pmc/journals/">Journal list</a>\n                    </li><li class="help">\n                        <a target="_blank" href="/books/NBK3825/">Help</a>\n                    </li></ul></div>\n</div>\n\n                            \n                            \n                        <!--<component id="Page" label="headcontent"/>-->\n                            \n                        </div>\n                        <div class="content">\n                            <!-- site messages -->\n                            <div class="container">\n    <div id="maincontent" class="content eight_col col">\n        <div class="navlink-box">\n            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=hhs%20author%20manuscript[filter]" class="navlink">HHS Author Manuscripts</a></li><li class="accid">PMC2834826</li></ul>\n        </div>\n\n        <!-- Journal banner -->\n        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-hhspa.png" alt="Logo of nihpa" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,57,255,75" alt="About Author manuscripts" title="About Author manuscripts" href="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html" ref="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html" /><area shape="rect" coords="256,57,500,75" alt="Submit a manuscript" title="Submit a manuscript" href="https://www.nihms.nih.gov/" ref="reftype=publisher&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="0,0,499,74" alt="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" title="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" href="https://www.ncbi.nlm.nih.gov/pmc/about/public-access/" ref="reftype=publisher&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /></map></div> </div>\n        \n        <!--component id=\'MainPortlet\' label=\'search-reference\'/-->\n        \n        <!-- Book content -->\n        <div class="">\n            \n        \n            \n            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [\'h2\'], headingExclude: \':hidden\'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><span id="pmcmata">Nat Med</span>. Author manuscript; available in PMC 2010 Sep 1.</div><div></div><div>Published in final edited form as:</div><div style="margin-left:1em"><div class="fm-vol-iss-date"><a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=20111039" target="pmc_ext" ref="reftype=publisher&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access"><span class="cit">Nat Med. 2010 Mar; 16(3): 334\xe2\x80\x93338. </span></a></div><span class="fm-vol-iss-date">Published online 2010 Jan 28. </span> <span class="doi">doi:\xc2\xa0<a href="//dx.doi.org/10.1038%2Fnm.2105" target="pmc_ext" ref="reftype=other&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1038/nm.2105</a></span></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC2834826</span></div><div class="fm-citation-manuscriptid"><span class="fm-citation-ids-label">NIHMSID: </span><span>NIHMS172047</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/20111039">20111039</a></div></div></div></div><h1 class="content-title">A VLP vaccine for epidemic Chikungunya virus protects non-human primates against infection</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Akahata%20W%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20111039" class="affpopup" co-rid="_co_idm140119615468928" co-class="co-affbox">Wataru Akahata</a>,<sup>1</sup> <a href="/pubmed/?term=Yang%20Zy%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20111039" class="affpopup" co-rid="_co_idm140119618743712" co-class="co-affbox">Zhi-yong Yang</a>,<sup>1</sup> <a href="/pubmed/?term=Andersen%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20111039" class="affpopup" co-rid="_co_idm140119623475632" co-class="co-affbox">Hanne Andersen</a>,<sup>2</sup> <a href="/pubmed/?term=Sun%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20111039" class="affpopup" co-rid="_co_idm140119623644880" co-class="co-affbox">Siyang Sun</a>,<sup>3</sup> <a href="/pubmed/?term=Holdaway%20HA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20111039" class="affpopup" co-rid="_co_idm140119610244224" co-class="co-affbox">Heather A. Holdaway</a>,<sup>3</sup> <a href="/pubmed/?term=Kong%20WP%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20111039" class="affpopup" co-rid="_co_idm140119614994688" co-class="co-affbox">Wing-Pui Kong</a>,<sup>1</sup> <a href="/pubmed/?term=Lewis%20MG%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20111039" class="affpopup" co-rid="_co_idm140119621312048" co-class="co-affbox">Mark G. Lewis</a>,<sup>2</sup> <a href="/pubmed/?term=Higgs%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20111039" class="affpopup" co-rid="_co_idm140119618902096" co-class="co-affbox">Stephen Higgs</a>,<sup>4</sup> <a href="/pubmed/?term=Rossmann%20MG%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20111039" class="affpopup" co-rid="_co_idm140119623142896" co-class="co-affbox">Michael G. Rossmann</a>,<sup>3</sup> <a href="/pubmed/?term=Rao%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20111039" class="affpopup" co-rid="_co_idm140119619433536" co-class="co-affbox">Srinivas Rao</a>,<sup>1</sup> and  <a href="/pubmed/?term=Nabel%20GJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20111039" class="affpopup" co-rid="_co_idm140119621523264" co-class="co-affbox">Gary J. Nabel</a><sup>1,</sup><sup>*</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140119615468928"><h3 class="no_margin">Wataru Akahata</h3><p><sup>1</sup> Vaccine Research Center NIAID, National Institutes of Health Bethesda, MD 20892-3005</p><div>Find articles by <a href="/pubmed/?term=Akahata%20W%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20111039">Wataru Akahata</a></div></div><div id="_co_idm140119618743712"><h3 class="no_margin">Zhi-yong Yang</h3><p><sup>1</sup> Vaccine Research Center NIAID, National Institutes of Health Bethesda, MD 20892-3005</p><div>Find articles by <a href="/pubmed/?term=Yang%20Zy%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20111039">Zhi-yong Yang</a></div></div><div id="_co_idm140119623475632"><h3 class="no_margin">Hanne Andersen</h3><p><sup>2</sup> Bioqual, Inc. Rockville, MD 20850-3336</p><div>Find articles by <a href="/pubmed/?term=Andersen%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20111039">Hanne Andersen</a></div></div><div id="_co_idm140119623644880"><h3 class="no_margin">Siyang Sun</h3><p><sup>3</sup> Department of Biological Sciences Purdue University West Lafayette, IN 47907-2054</p><div>Find articles by <a href="/pubmed/?term=Sun%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20111039">Siyang Sun</a></div></div><div id="_co_idm140119610244224"><h3 class="no_margin">Heather A. Holdaway</h3><p><sup>3</sup> Department of Biological Sciences Purdue University West Lafayette, IN 47907-2054</p><div>Find articles by <a href="/pubmed/?term=Holdaway%20HA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20111039">Heather A. Holdaway</a></div></div><div id="_co_idm140119614994688"><h3 class="no_margin">Wing-Pui Kong</h3><p><sup>1</sup> Vaccine Research Center NIAID, National Institutes of Health Bethesda, MD 20892-3005</p><div>Find articles by <a href="/pubmed/?term=Kong%20WP%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20111039">Wing-Pui Kong</a></div></div><div id="_co_idm140119621312048"><h3 class="no_margin">Mark G. Lewis</h3><p><sup>2</sup> Bioqual, Inc. Rockville, MD 20850-3336</p><div>Find articles by <a href="/pubmed/?term=Lewis%20MG%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20111039">Mark G. Lewis</a></div></div><div id="_co_idm140119618902096"><h3 class="no_margin">Stephen Higgs</h3><p><sup>4</sup> Department of Pathology University of Texas Medical Branch Galveston, TX 77555-0609</p><div>Find articles by <a href="/pubmed/?term=Higgs%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20111039">Stephen Higgs</a></div></div><div id="_co_idm140119623142896"><h3 class="no_margin">Michael G. Rossmann</h3><p><sup>3</sup> Department of Biological Sciences Purdue University West Lafayette, IN 47907-2054</p><div>Find articles by <a href="/pubmed/?term=Rossmann%20MG%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20111039">Michael G. Rossmann</a></div></div><div id="_co_idm140119619433536"><h3 class="no_margin">Srinivas Rao</h3><p><sup>1</sup> Vaccine Research Center NIAID, National Institutes of Health Bethesda, MD 20892-3005</p><div>Find articles by <a href="/pubmed/?term=Rao%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20111039">Srinivas Rao</a></div></div><div id="_co_idm140119621523264"><h3 class="no_margin">Gary J. Nabel</h3><p><sup>1</sup> Vaccine Research Center NIAID, National Institutes of Health Bethesda, MD 20892-3005</p><div>Find articles by <a href="/pubmed/?term=Nabel%20GJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20111039">Gary J. Nabel</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140119618676320_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140119618676320_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140119618676320_ai" style="display:none"><div class="fm-affl" lang="en" id="A1"><sup>1</sup> Vaccine Research Center NIAID, National Institutes of Health Bethesda, MD 20892-3005</div><div class="fm-affl" lang="en" id="A2"><sup>2</sup> Bioqual, Inc. Rockville, MD 20850-3336</div><div class="fm-affl" lang="en" id="A3"><sup>3</sup> Department of Biological Sciences Purdue University West Lafayette, IN 47907-2054</div><div class="fm-affl" lang="en" id="A4"><sup>4</sup> Department of Pathology University of Texas Medical Branch Galveston, TX 77555-0609</div><div id="FN1"><strong>AUTHOR CONTRIBUTIONS</strong> W.A, Z.Y.Y., S.H., S.R. and G.J.N. designed the research studies; W.A., Z.Y.Y., H.A., S.S., H.A.H., W.P.K., M.L. and S.R. performed the research; W.A. and Z.Y.Y. contributed to development and generation of vectors; and W.A., Z.Y.Y., H.A., S.S., H.A.H., W.P.K., M.L., S.H., M.G.R., S.R. and G.J.N. analyzed data; and W.A., Z.Y.Y., S.H., M.G.R., S.R., and G.J.N. wrote the paper.</div><div id="CR1"><sup>*</sup> To whom correspondence should be addressed. Tel: 301-496-1852 Fax: 301-480-0274 <a href="mailto:dev@null" data-email="vog.hin@lebang" class="oemail">vog.hin@lebang</a></div></div><div class="fm-article-notes fm-panel half_rhythm"></div><div class="permissions fm-panel half_rhythm hide" id="idm140119618676320_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright notice</a> </div><div class="license half_rhythm">Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:\n<a href="http://www.nature.com/authors/editorial_policies/license.html#terms">http://www.nature.com/authors/editorial_policies/license.html#terms</a></div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>The publisher\'s final edited version of this article is available  at <a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=20111039" target="pmc_ext" ref="reftype=publisher&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access">Nat Med</a></div><div>See other articles in PMC that <a href="/pmc/articles/PMC2834826/citedby/">cite</a> the published article.</div></div></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><h2>Associated Data</h2><dl data-count="1" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>1.</strong></div><div><a href="/pmc/articles/PMC2834826/bin/NIHMS172047-supplement-1.doc" data-ga-action="click_feat_suppl">NIHMS172047-supplement-1.doc</a><span style="color:gray"> (575K)</span></div><div class="small guid">GUID:\xc2\xa08E40AEB8-EEA1-4064-B4B4-234C81EF8517</div></div></dd></dl></div><div id="idm140119614353664" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140119614353664title">Abstract</h2><!--article-meta--><div><p id="P2" class="p p-first-last">Chikungunya virus (CHIKV) has infected millions of people in Africa, Europe, and Asia<sup><a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930899">1</a></sup><sup>,</sup><sup><a href="#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930906">2</a></sup> since its re-emergence in Kenya in 2004. The severity of disease and spread of this epidemic virus present a serious public health threat in the absence of vaccines or anti-viral therapies. Here, we describe a novel vaccine that protects against emerging CHIKV infection of non-human primates (NHP). We show that selective expression of viral structural proteins gives rise to virus-like particles (VLPs) <em>in vitro</em> that resemble replication-competent alphaviruses. Immunization with these VLPs elicited neutralizing antibodies against envelope proteins from different CHIKV strains. Monkeys immunized with VLPs produced high titer neutralizing antibodies that protected against viremia after high dose challenge. We transferred these antibodies into immunodeficient mice, where they protected against subsequent lethal CHIKV challenge, establishing a humoral mechanism of protection. Immunization with alphavirus VLP vaccines represents a strategy to contain the spread of CHIKV and related pathogenic viruses in humans.</p></div></div><div id="idm140119618736576" class="tsec sec headless whole_rhythm"><p id="P3" class="p p-first">Chikungunya virus (CHIKV), a mosquito-borne <em>alphavirus</em> in the family <em>Togaviridae</em>, was first isolated in Tanzania in 1952<sup><a href="#R3" rid="R3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930887">3</a></sup>. Infection by this virus in humans is characterized by rash, high fever and, its hallmark feature, severe arthritis that can persist for years<sup><a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930915">1</a></sup><sup>,</sup><sup><a href="#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930921">2</a></sup>. An epidemic strain of CHIKV appeared on Reunion Island in 2005 and has since spread to more than 18 countries<sup><a href="#R4" rid="R4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930924">4</a></sup> (see also <a href="http://www.cdc.gov/ncidod/dvbid/chikungunya/CH_GlobalMap.html" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www.cdc.gov/ncidod/dvbid/chikungunya/CH_GlobalMap.html</a>). Dissemination of this epidemic virus is associated with genetic mutations that facilitate adaptation to a new insect vector, the Asian tiger mosquito, <em>Aedes albopictus</em><sup><a href="#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930888">5</a></sup>, that survives in temperate climates and is widely distributed<sup><a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930920">6</a></sup>. CHIKV continues to cause substantial morbidity resulting in significant economic losses, and vaccine development remains a high priority.</p><p id="P4">CHIKV is composed of a positive single strand genomic RNA of 12,000 nucleotides encoding four nonstructural and five structural polyproteins<sup><a href="#R7" rid="R7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930938">7</a></sup>. The nonstructural proteins, nsP1, nsP2, nsP3 and nsP4, are required for virus replication; the structural proteins, which consist of capsid (C) and envelope proteins (E; E1, E2, E3 and 6K), are synthesized as polyproteins and are cleaved by capsid autoproteinase and signalases<sup><a href="#R7" rid="R7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930889">7</a></sup> (<a href="/pmc/articles/PMC2834826/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1a</span></a>, upper panel). Based on the similarity of CHIKV to other alphaviruses, CHIKV has spikes on the virion surface that are each formed by three E1-E2 heterodimers<sup><a href="#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930898">8</a></sup><sup>,</sup><sup><a href="#R9" rid="R9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930885">9</a></sup>, where the E1 glycoproteins mediate fusion and E2 glycoproteins interact with the host receptor<sup><a href="#R7" rid="R7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930905">7</a></sup>. Phylogenetic analysis of CHIKV has revealed three genotypes: Asian, East/Central/South African and West African. All strains are highly related, with 95.2&#x02013;99.8% amino acid similarity<sup><a href="#R10" rid="R10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930937">10</a></sup>. Although CHIKV strains vary, individual strains are antigenically related, so it is potentially possible to design a vaccine that works against heterologous strains<sup><a href="#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930929">11</a></sup>.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC2834826/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140119624899904" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2834826_nihms-172047-f0001.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-172047-f0001.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2834826/bin/nihms-172047-f0001.jpg" /></a></div><div id="largeobj_idm140119624899904" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2834826/figure/F1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC2834826/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Characterization of CHIKV E pseudotyped lentiviral vectors</strong><p id="__p2">(<strong>a</strong>) Schematic representation of the CHIKV genome and CHIKV E expression vector used for incorporation of CHIKV E from strains 37997 and LR2006 OPY-1 into pseudotyped lentiviral vectors. The CHIKV genome consists of nonstructural polyproteins nsP1, nsP2, nsP3 and nsP4 and structural polyproteins capsid (C) and envelope (E: E3, E2, 6K and E1) (top). The polypeptide E genes from strains 37997 and LR2006 OPY-1 were inserted into an expression vector (bottom; schematic representation of vector is in <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Fig. 1a</a>, top). (<strong>b</strong>) Infectivity of the indicated pseudotyped lentiviral vectors in several CHIKV-permissive cell lines including 293A human renal epithelial, HeLa cervical epithelial, Vero renal epithelial and baby hamster kidney (BHK) cells. The pseudotyped vectors were standardized by HIV-1 Gag p24 (left) or the indicated concentration of p24 and used to infect 293A cells (right). After incubation with pseudotyped vectors for 24 h, cells were lysed and luciferase activity was measured. (<strong>c</strong>) pH-dependent entry of CHIKV pseudotyped lentiviral vectors incubated in the presence of the indicated amounts of ammonium chloride (left) and chloroquine (right). Data are presented as the percentage of activity at the indicated dose relative to activity with no treatment. (<strong>d</strong>) Neutralization measured with pseudotyped lentiviral vectors in sera from immune mice infected with CHIKV strain S-27 (ATCC). Sera were incubated at the indicated dilutions with VSV-G, CHIKV strain 37997 or LR2006 OPY-1 E-pseudotyped lentiviral vectors and the mixture infected to 293A cells. No inhibition was observed with control non-immune antisera.</p></div></div></div><p id="P5">We first analyzed the immunogenicity and cross-reactivity of two disparate strains, 37997 from the older West Africa lineage and LR2006 OPY-1, the more recent strain responsible for the current epidemic. To examine the specificity of viral cell entry and their sensitivity to neutralizing antibodies, we developed lentiviral vector reporters pseudotyped with glycoproteins from these different CHIKV strains. Such vectors allow analysis of the mechanism and the specificity of entry and serve to quantitate antibody neutralization more readily than wild type viruses that pose significant biohazard concerns for routine laboratory analyses. They therefore provide a useful tool for the study of CHIKV entry as well as for vaccine development<sup><a href="#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930925">12</a></sup><sup>-</sup><sup><a href="#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930902">14</a></sup>. We inserted CHIKV E genes expressing the native polypeptide, E3-E2-6K-E1 (<a href="/pmc/articles/PMC2834826/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1a</span></a>, lower panel), for the 37997 and LR2006 OPY-1 strains into an expression vector (E<sub>37997</sub> and E<sub>OPY-1</sub>). Incorporation of the two CHIKV Es into the pseudotyped lentiviral vectors was verified by buoyant density gradient sedimentation of the virus. Both CHIKV E and HIV-1 Gag had the same buoyant density as lentivirus particles (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Fig. 1</a>). The 37997 and LR2006 OPY-1 CHIKV pseudotyped lentiviral vectors infected several cell lines permissive for viral replication<sup><a href="#R15" rid="R15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930895">15</a></sup> (<a href="/pmc/articles/PMC2834826/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1b</span></a>, left). We measured their ability to express a luciferase reporter in 293A human renal epithelial cells and found that entry was dose-dependent (<a href="/pmc/articles/PMC2834826/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1b</span></a>, right), while a control devoid of CHIKV envelope proteins did not infect these cell lines. To determine whether entry occurred through the same mechanism as native virus, we analyzed pH and endosome dependence of entry <sup><a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930894">13</a></sup>. CHIKV infects through pH-dependent cell fusion<sup><a href="#R15" rid="R15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930904">15</a></sup>; thus, addition of ammonium chloride or chloroquine, which prevents acidification of the endosome, caused a dose-dependent reduction in CHIKV pseudotyped vector entry (<a href="/pmc/articles/PMC2834826/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1c</span></a>). We observed similar inhibition of entry with VSV-G, known to enter in this fashion, but not with amphotropic murine leukemia virus (MuLV) glycoprotein 70, which enters by a pH-independent mechanism<sup><a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930927">13</a></sup><sup>,</sup><sup><a href="#R16" rid="R16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930893">16</a></sup>. These findings demonstrated that lentiviral vectors pseudotyped with CHIKV envelope mediated entry through the same mechanism as wild type virus. Next, we examined a commercially available immune serum from mice infected with an established CHIKV strain (ATCC). Incubation of immune sera with the CHIKV pseudotyped lentiviral vector, but not a VSV-G pseudotyped vector, inhibited entry (<a href="/pmc/articles/PMC2834826/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1d</span></a>). The specificity and potency of neutralizing antibodies could therefore be quantified without exposure to infectious virus.</p><p id="P6">We analyzed eukaryotic expression vectors encoding C-E3-E2-6K-E1 from strains 37997 and LR2006 OPY-1 (C-E<sub>37997</sub> and C-E<sub>OPY-1</sub>) for their ability to give rise to VLPs. We transfected 293T human kidney cells with plasmids C-E<sub>37997</sub> or C-E<sub>OPY-1</sub> or the E expression vectors described above, E<sub>37997</sub> or E<sub>OPY-1</sub> (<a href="/pmc/articles/PMC2834826/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2a</span></a>, upper panel), and confirmed expression in the cell lysates by Western blotting (<a href="/pmc/articles/PMC2834826/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2a</span></a>, lower panel). We also detected C and E1/E2 proteins in the supernatant by Western blotting after transfection of the C-E<sub>37997</sub> or C-E<sub>OPY-1</sub> vector, suggesting that CHIKV VLPs had been generated. We purified VLPs by buoyant density gradient sedimentation. The yield of VLPs from strain 37997 was 10&#x02013;20 mg L<sup>&#x02212;1</sup> &#x02013; approximately 100 times higher than that from strain LR2006 OPY-1. For this reason and because of the high degree of amino acid similarity among CHIKV strains, we used the 37997 strain to produce VLPs. Fractionation of clarified supernatant showed greatest incorporation of E1/E2 into the VLPs at a density of 1.2 g mL<sup>&#x02212;1</sup> (<a href="/pmc/articles/PMC2834826/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2b</span></a>, left), comparable to the density of wild type CHIKV<sup><a href="#R17" rid="R17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930919">17</a></sup>. Examination of the purified fraction from strain 37997 by electron microscopy revealed VLPs with the same morphologic appearance as wild type virus (<a href="/pmc/articles/PMC2834826/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2b</span></a>, right).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC2834826/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140119620103728" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2834826_nihms-172047-f0002.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-172047-f0002.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2834826/bin/nihms-172047-f0002.jpg" /></a></div><div id="largeobj_idm140119620103728" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2834826/figure/F2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC2834826/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Figure 2</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Characterization of CHIKV VLPs</strong><p id="__p3">(<strong>a</strong>) Schematic representation of CHIKV C-E or E expression vectors used for DNA vaccine and VLP production. The CHIKV structural polyproteins capsid plus envelope (C-E) or E alone from strains 37997 and LR2006 OPY-1 were inserted into a CMV/R expression vector<sup><a href="#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930909">14</a></sup> (<strong>Methods</strong>). 293T cells were transfected with the indicated plasmids. Expression was measured 48 h after transfection by Western blotting<sup><a href="#R32" rid="R32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930934">32</a></sup> as described (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Methods</a>) (<strong>b</strong>) VLPs were purified (<strong>Methods</strong>)from the supernatants of 293F cells transfected with C-E expression vector (C-E<sub>37997</sub>) (left) 72 h after transfection. Each fraction was characterized for its buoyant density (left upper panel) and protein content (left lower panel) by Western blot analysis. The fractionated VLPs were observed by transmission electron microscopy with magnification 20,000&#x000d7; (right, bar 100 nm). (<strong>c</strong>) Cryo-EM reconstruction of CHIKV VLP reveals its structural similarity to alphaviruses. Shaded-surface representation of the 3D density map of CHIKV VLP is viewed along an icosahedral 2-fold axis and resembles Sindbis virus (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Fig. 2</a>; see also refs. <sup><a href="#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930900">8</a></sup><sup>,</sup><sup><a href="#R9" rid="R9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930936">9</a></sup><sup>,</sup><sup><a href="#R18" rid="R18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930930">18</a></sup>). The white triangle marks the boundary of an icosahedral asymmetric unit. The numbers show the positions of the icosahedral 2-, 3-, and 5-fold axes limiting an asymmetric unit. The central cross-section through the cryo-EM maps of CHIKV VLP (left) and Sindbis virus (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Fig. 2</a>) are similar. The orientations of the icosahedral (2-, 3-, and 5-fold) axes as well as the quasi-threefold (q3) axis are shown with white lines. The map is calculated to 18 &#x000c5; resolution.</p></div></div></div><p id="P7">Cryoelectron microscopy and three dimensional image reconstruction, assuming icosahedral symmetry, showed that the VLPs had an external diameter of 65 nm and a core diameter of 40 nm (<a href="/pmc/articles/PMC2834826/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2c</span></a>). The potent immunogenic E1/E2 glycoproteins are organized into 240 heterodimers, assembled into 80 glycoprotein spikes arranged with T=4 quasi symmetry on the surface of the VLPs (<a href="/pmc/articles/PMC2834826/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2c</span></a>), closely similar to the structure of Sindbis virus (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Fig. 2</a>; see also refs. <sup><a href="#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930922">8</a></sup><sup>,</sup><sup><a href="#R9" rid="R9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930903">9</a></sup><sup>,</sup><sup><a href="#R18" rid="R18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930931">18</a></sup>).</p><p id="P8">Because of the ease of DNA vaccine preparation and its broad applicability, we compared the relative immunogenicity of plasmid DNA to VLP vaccines in mice by immunizing with DNA vaccines encoding C-E or E (strains 37997 and LR2006 OPY-1) or VLPs from strain 37997 (VLP<sub>37997</sub>) in the presence or absence of Ribi adjuvant. BALB/c mice injected twice intramuscularly with VLPs with adjuvant generated the highest titer neutralizing responses against both the homologous strain 37997 (<a href="/pmc/articles/PMC2834826/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3a</span></a>, right panel; IC<sub>50</sub>, 1:10,703) and the heterologous strain LR2006 OPY-1 (<a href="/pmc/articles/PMC2834826/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3b</span></a>, right panel; IC<sub>50</sub>, 1:54,600). While three immunizations with the plasmids encoding C-E and E from both strains elicited neutralizing responses, these titers were less than five percent those of VLP-immunized mice (<a href="/pmc/articles/PMC2834826/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3a, b</span></a>; left panel; IC<sub>50</sub> titer of 319 for DNA C-E<sub>37997</sub> against strain 37997; 525 for DNA C-E<sub>37997</sub> against strain LR2006 OPY-1). These results suggested that VLPs elicited a more potent neutralizing antibody response than DNA vaccines.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F3" co-legend-rid="lgnd_F3"><a href="/pmc/articles/PMC2834826/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140119612850272" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2834826_nihms-172047-f0003.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-172047-f0003.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2834826/bin/nihms-172047-f0003.jpg" /></a></div><div id="largeobj_idm140119612850272" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2834826/figure/F3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F3"><div><a class="figpopup" href="/pmc/articles/PMC2834826/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3">Figure 3</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Neutralization of CHIKV strains 37997 and LR2006 OPY-1 after DNA or VLP vaccination in mice and monkeys</strong><p id="__p4">(<strong>a</strong>) and (<strong>b</strong>) Sera from immunized BALB/c mice 10 days after the final immunization were tested with CHIKV strain 37997 (<strong>a</strong>) or LR2006 OPY-1 (<strong>b</strong>) E pseudotyped lentiviral vectors. Mice were immunized with the indicated 15 &#x003bc;g of DNA or 19 &#x003bc;g of VLP<sub>37997</sub>. Each C-E or E (strain 37997 and LR2006 OPY-1, respectively) plasmid was injected intramuscularly three times at 0, 3 and 6 weeks. VLP<sub>37997</sub> with or without Ribi adjuvant was injected twice at 2 and 6 weeks. The experiment was performed in triplicate. The symbols show the average of the five mice and bars show the standard error of the mean. The curve fit was calculated by Prism software. (<strong>c</strong>) Rhesus monkeys were immunized with 20 &#x003bc;g of VLP<sub>37997</sub> or PBS (control) intramuscularly three times at 0, 4, and 24 weeks. A neutralizing assay was performed with CHIKV strain 37997 (left panel) or LR2006 OPY-1 (right panel) E pseudotyped lentiviral vectors in sera collected from immunized monkeys at 10 days after each immunization. The symbols show the average of the six monkeys and bars show the standard error of the mean. (<strong>d</strong>) Neutralizing activity against CHIKV LR2006 OPY-1 in immunized monkeys&#x02019; sera after the 2nd and 3rd immunizations was confirmed by a standard plaque reduction neutralization test (PRNT). The symbols show the average of the six monkeys and bars show the standard error of the mean.</p></div></div></div><p id="P9">To characterize VLP-induced immune responses in a model with stronger predictive value for humans, we immunized rhesus macaques with VLPs. Monkeys received intramuscular injections of VLP<sub>37997</sub> or PBS alone as a control. We tested sera from immunized and control monkeys against CHIKV strain 37997 and LR2006 OPY-1 pseudotyped lentiviral vectors. All non-human primates (NHP) immunized with VLPs developed substantial neutralizing activity to both homologous and heterologous strains after primary immunization that increased after boosting (<a href="/pmc/articles/PMC2834826/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3c</span></a>; left panel: IC<sub>50</sub> titer of 10,219 against strain 37997, right panel: IC<sub>50</sub> titer of 15,072 against strain LR2006 OPY-1). Interestingly, there was slightly increased neutralization of LR2006 OPY-1 compared to 37997 in both mice and monkeys, although these effects were not substantial, suggesting that LR2006 OPY-1 may present a common epitope to the immune system somewhat better than 37997. To confirm that these antibodies neutralized infectious virus, we performed a plaque reduction neutralization test (PRNT) against the CHIKV LR2006 OPY-1. The antisera from the immunized monkeys elicited neutralizing antibody responses against LR2006 OPY-1 at PRNT<sub>50</sub> titers of 40,133 (<a href="/pmc/articles/PMC2834826/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3d</span></a>). These data suggested that neutralizing antibodies using pseudotyped lentiviral vectors correlated with the PRNT assay, and that all VLP-immunized monkeys generated potent neutralizing antibody responses against CHIKV.</p><p id="P10">To establish the CHIKV challenge model in monkeys, we injected two na&#x000ef;ve rhesus monkeys intravenously with a high titer LR2006 OPY-1 virus stock. Viremia commenced at 6 h and lasted until at least 72 h after challenge in these monkeys, with the peak viremia at 24 h after infection (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Fig. 3a</a>). Similar to humans, infection in NHPs resulted in viremia and was not lethal. In addition, we observed a similar transient acute lymphopenia and a pro-inflammatory response as measured by transient neutrophilia and an increase in monocyte counts (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Fig. 3b</a>). We assessed the ability of the VLP vaccine to protect against infection by intravenous challenge of monkeys immunized with VLPs or controls using the same high titer LR2006 OPY-1 virus stock 15 weeks after the final immunization. In this model, all immunized monkeys controlled the challenge virus completely (<a href="/pmc/articles/PMC2834826/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig. 4a</span></a>). In contrast, we observed viremia in all the control monkeys injected with CHIKV, as in the pilot experiment. Similarly, monocyte counts were markedly increased in control monkeys 4 days after challenge, while they remained unchanged in vaccinated monkeys (<a href="/pmc/articles/PMC2834826/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig. 4b</span></a>, Control, at day 0 vs. 7, <em>P</em> = 0.0015; VLPs at day 0 vs. 7, <em>P</em> = 0.38). These data suggest that immunization protected against both viremia and the inflammatory consequences of infection.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F4" co-legend-rid="lgnd_F4"><a href="/pmc/articles/PMC2834826/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140119618331648" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2834826_nihms-172047-f0004.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms-172047-f0004.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2834826/bin/nihms-172047-f0004.jpg" /></a></div><div id="largeobj_idm140119618331648" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2834826/figure/F4/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F4"><div><a class="figpopup" href="/pmc/articles/PMC2834826/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4">Figure 4</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Protection against CHIKV LR2006 OPY-1 challenge in monkeys immunized with VLPs and in a CHIKV mouse model after passive transfer of purified IgG</strong><p id="__p5">(<strong>a</strong>) Monkeys injected with PBS (Control) or immunized with VLP<sub>37997</sub> were challenged intravenously with 10<sup>10</sup> PFU of the CHIKV strain LR2006 OPY-1 15 weeks after the final boost. The peak viremia at 24 h after challenge was measured by plaque assay. The detection limit was 1000 PFU per mL. Error bars represent the standard error of the mean. (<strong>b</strong>) The percentage of monocytes in the monkeys&#x02019; white blood cells was measured using a hematology analyzer before and 7 days after challenge with CHIKV. Error bars represent the standard error of the mean. An unpaired two-tailed <em>t</em> test was used for statistical analysis (Control at day 0 vs. 7, <em>P</em> = 0.0015; VLPs at day 0 vs. 7, <em>P</em> = 0.38; Control vs. VLPs at 7 days, <em>P</em> = 0.0036). (<strong>c</strong>) Purified IgG from a monkey immunized with VLPs (Immune) or a control monkey (Control IgG) was passively transferred into IFN-&#x003b1;/&#x003b2;R<sup>-/-</sup> mice intravenously (2 mg of total IgG per mouse, n=5 per group). Recipient mice were challenged 24 h after IgG transfer with a lethal LR2006 OPY-1 challenge (30 PFU) by intradermal injection. The viremia in the mice after challenge was measured by quantitative RT-PCR (limit of detection = 40 RNA copies per mL). Error bars represent the standard error of the mean. (<strong>d</strong>) Survival curve of mice passively transferred with control IgG or CHIKV immunized IgG against lethal LR2006 OPY-1 challenge.</p></div></div></div><p id="P11">To define the mechanism of protection in these animals, we investigated whether or not immune IgG could protect against lethal challenge using an adoptive transfer model. Previous studies have shown that immunodeficient mice with defective type-I interferon signaling are susceptible to lethal CHIKV infection, displaying pathologic manifestations of infection<sup><a href="#R19" rid="R19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930918">19</a></sup>, and providing a model to evaluate immune mechanisms of protection. For example, Couderc <em>et. al</em><sup><a href="#R20" rid="R20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_849301837">20</a></sup> showed that antibodies play an important role in protecting against CHIKV infection by passive transfer of IgG from infected humans in this model. Here, we intravenously transferred purified total IgG from immunized or control monkeys into these mice, then challenged the recipient mice intradermally with a lethal dose of LR2006 OPY-1 24 h later. Recipients of purified IgG from CHIKV-immunized monkeys demonstrated no detectable viremia after challenge and were completely protected from lethality (<a href="/pmc/articles/PMC2834826/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig. 4c,d</span></a>). In contrast, all mice that received purified IgG from control monkeys showed severe infection and viremia, and all died. These results indicate that humoral immune responses induced by CHIKV VLPs conferred protection against CHIKV infection.</p><p id="P12">To date, there has been limited success in developing a safe and effective CHIKV vaccine. A live attenuated CHIKV vaccine candidate<sup><a href="#R21" rid="R21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930911">21</a></sup><sup>,</sup><sup><a href="#R22" rid="R22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930917">22</a></sup> caused transient arthralgia in volunteers<sup><a href="#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930908">23</a></sup>. Other efforts include a formalin-killed vaccine<sup><a href="#R24" rid="R24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930935">24</a></sup><sup>,</sup><sup><a href="#R25" rid="R25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930901">25</a></sup>, a Venezuelan equine encephalitis/CHIKV chimeric live attenuated vaccine<sup><a href="#R26" rid="R26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930926">26</a></sup> and a consensus-based DNA vaccine<sup><a href="#R27" rid="R27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930907">27</a></sup> that have not yet proven both safe and effective. Development of a safe and effective CHIKV vaccine will require additional evaluation in humans. However, the safety and efficacy of VLP vaccines in general make them promising candidates for further study.</p><p id="P13" class="p">VLPs are known to be highly immunogenic and elicit higher titer neutralizing antibody responses than subunit vaccines based on individual proteins<sup><a href="#R28" rid="R28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930916">28</a></sup><sup>-</sup><sup><a href="#R30" rid="R30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930896">30</a></sup>. Such VLPs authentically present viral spikes and other surface components in a repetitive array that effectively elicits recognition by B-cells to stimulate antibody secretion<sup><a href="#R28" rid="R28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930897">28</a></sup><sup>,</sup><sup><a href="#R29" rid="R29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930914">29</a></sup>. This recognition leads to B cell signaling and MHC class II up-regulation that facilitates the generation of high titer specific antibodies. VLPs from other viruses, including hepatitis B virus and human papillomavirus, elicit high titer neutralizing antibody responses that contribute to protective immunity in humans<sup><a href="#R30" rid="R30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930933">30</a></sup><sup>,</sup><sup><a href="#R31" rid="R31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_849301836">31</a></sup>. The vaccines described here represent the first use of recombinant VLPs to prevent infection by <em>alphaviruses</em>. At a time when there are no commercially available vaccines and CHIKV is emerging, it has the potential to significantly impact the spread of this disease. Changes in trade, travel and global climate have aided the spread of mosquito species worldwide, which may potentially cause other <em>alphavirus</em> outbreaks. This approach to vaccine development may prove useful for other <em>alphaviruses</em> of increasing concern, including Western, Eastern, and Venezuelan equine encephalitis viruses, o&#x02019;nyong-nyong virus and Ross River virus.</p></div><div id="S1" class="tsec sec"><h2 class="head no_bottom_margin" id="S1title">METHODS</h2><div id="S2" class="sec sec-first"><h3 id="S2title">Vector construction</h3><p id="P14" class="p p-first-last">We synthesized plasmids encoding structural polyproteins C, E1, E2, E3 and 6K (strains 37997 and LR2006 OPY-1, GenBank <a id="__tag_849301838" class="tag_hotlink" href="/nuccore/EU224270" ref="/nuccore/EU224270"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"EU224270","term_id":"160426356","term_text":"EU224270"}}</span>EU224270</a> and <a id="__tag_511930959" class="tag_hotlink" href="/nuccore/EU224268" ref="/nuccore/EU224268"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"EU224268","term_id":"160426349","term_text":"EU224268"}}</span>EU224268</a>, respectively) as previously described<sup><a href="#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930891">14</a></sup> (GeneArt). We amplified plasmids encoding the polyproteins E3, E2, 6K, and E1 by PCR using sense primer 5&#x02032;-GCTCTAGACACCATGAGCCTCGCCCTCCCGGTCTTG-3&#x02032; and antisense primer 5&#x02032;-TGGATCCTCATTAGTGCCTGCTAAACGACA-3&#x02032; (37997) and sense primer 5&#x02032;-GCTCTAGACACCATGAGTCTTGCCATCCCAGTTATG-3&#x02032; and antisense primer 5&#x02032;-TGGATCCTCATTAGTGCCTGCTGAACGACA-3&#x02032; (LR2006 OPY-1). We inserted XbaI and BamHI sites for cloning. We digested each fragment with XbaI/BamHI and inserted it into a eukaryotic expression vector, CMV/R<sup><a href="#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930932">14</a></sup> (C-E<sub>37997</sub>, C-E<sub>OPY-1</sub>, E<sub>37997</sub> and E<sub>OPY-1</sub>). The CMV/R vector comprises the human CMV IE enhancer/promoter, an HTLV-1 R region containing a splicing donor, a CMV IE splicing acceptor and bovine growth hormone poly A signal.</p></div><div id="S3" class="sec"><h3 id="S3title">Production of pseudotyped lentiviral vectors</h3><p id="P15" class="p p-first-last">We created lentiviral vectors expressing glycoproteins from different CHIKV strains. The method for producing recombinant lentiviral vectors expressing a luciferase reporter gene has been previously described<sup><a href="#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930890">12</a></sup><sup>,</sup><sup><a href="#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930910">14</a></sup>. Briefly, we cotransfected 293T cells with 500 ng CHIKV E plasmid from either strain (E<sub>37997</sub> or E<sub>OPY-1</sub>), 7 &#x003bc;g of a transducing vector encoding a luciferase reporter gene under the control of a CMV promoter (pHR&#x02019;CMV-luciferase plasmid), and 7 &#x003bc;g of a packaging plasmid that expresses all human immunodeficiency virus type 1 (HIV-1) structural proteins except envelope (pCMV&#x00394;R8.2) (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Fig. 1a</a>). Additional methods and neutralization assay with CHIKV E pseudotyped lentiviral vectors are described in the <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Methods</a>.</p></div><div id="S4" class="sec"><h3 id="S4title">Buoyant density gradient sedimentation analysis and purification of VLPs</h3><p id="P16" class="p p-first-last">We transfected 293F cells (2.5 &#x000d7; 10<sup>8</sup>) (Invitrogen) with 293fectin transfection reagent (Invitrogen) and 125 &#x003bc;g of C-E<sub>37997</sub> plasmid following the manufacturer&#x02019;s recommendations. Detailed methods for buoyant density gradient analysis and purification of VLPs have been described in a previous publication<sup><a href="#R32" rid="R32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930928">32</a></sup> and in the <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Methods</a>.</p></div><div id="S5" class="sec"><h3 id="S5title">Cryo-electron microscopy and image analysis</h3><p id="P17" class="p p-first-last">We flash-froze Chikungunya VLPs on holey grids in liquid ethane, and recorded images at 47K magnification with a CM300 FEG microscope with electron dose levels of approximately 20 e<sup>&#x02212;</sup>/&#x000c5;<sup><a href="#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930923">2</a></sup>. We digitized all micrographs at 6.35 &#x003bc;m per pixel using a Nikon scanner, and boxed individual particle images using the program e2boxer in the EMAN2 package<sup><a href="#R33" rid="R33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930912">33</a></sup>. We used the CTFIT program from the EMAN package<sup><a href="#R34" rid="R34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_511930886">34</a></sup> to determine CTF parameters and flip phases. We constructed an initial model in EMAN using assigned 2-, 3-, and 5-fold views and refined it in EMAN assuming icosahedral symmetry. The number of particles incorporated into the final reconstruction was 1489, giving a final resolution of 18 &#x000c5; based on a 0.5 Fourier shell correlation threshold.</p></div><div id="S6" class="sec"><h3 id="S6title">Immunizations and challenge of mice and monkeys</h3><p id="P18" class="p p-first-last">We mixed 19 &#x003bc;g of VLPs (equivalent to approximately 10 &#x003bc;g of E1/E2) in 60 &#x003bc;l normal saline with 60 &#x003bc;l of Ribi solution (Sigma Adjuvant system, Sigma-Aldrich) per mouse. We injected female 6- to 8-week-old BALB/c mice in the right and left quadriceps muscles with VLPs in normal saline or Ribi in 120 &#x003bc;l total volume, two times at weeks 2 and 6. For DNA vaccination, we injected mice in the right and left quadriceps with a total of 15 &#x003bc;g of purified plasmid C-E<sub>37997</sub>, E<sub>37997</sub>, C-E<sub>OPY-1</sub> or E<sub>OPY-1</sub> suspended in 100 &#x003bc;l of normal saline three times at weeks 0, 3 and 6. Each group contained five mice. We collected sera and spleen 10 days after the last injection. In monkey experiments, we injected 3&#x02013;4 year old rhesus macaques weighing 3&#x02013;4 kg intramuscularly in the anterior quadriceps with either 20 &#x003bc;g of VLPs in 1 mL PBS (VLP group) or 1 mL PBS alone (control group) at weeks 0, 4 and 24. Each group contained six monkeys. To measure antibody titers, we collected blood on days &#x02212;14, 0, 10, 28, 38, 56, 70, 161 and 178. We challenged the monkeys (<em>n</em>=3 per group, randomly selected from each group) with 10<sup>10</sup> PFU of CHIKV (strain LR2006 OPY-1) 15 weeks after the final immunization by intravenous injection. We collected blood to measure viremia at 0, 6, 24, 48, 72, 96, 120 and 168 hours, and sacrificed the monkeys 168 h after challenge. All animal experiments were reviewed and approved by the Animal Care and Use Committee, VRC, National Institute of Allergy and Infectious Diseases (<a href="http://www.niaid.nih.gov/vrc" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www.niaid.nih.gov/vrc</a>) in accordance with relevant federal guidelines and regulations.</p></div><div id="S7" class="sec"><h3 id="S7title">Passive transfer of immunoglobulin and challenge in IFN-&#x003b1;/&#x003b2;R<sup>-/-</sup> mice</h3><p id="P19" class="p p-first-last">We used a HiTrap&#x02122; Protein G HP column (GE Healthcare) and a Melon Gel IgG Purification Kit (Pierce) for antibody purification. We dialyzed purified IgG three times against PBS. We administered 2 mg of purified IgG (from approximately 200 &#x003bc;l of serum) into each recipient IFN-&#x003b1;/&#x003b2;R<sup>-/-</sup> mouse by tail vein injection 24 h before challenge. The challenge consisted of 30 PFU of CHIKV (strain LR2006 OPY-1), administered by intradermal injection.</p></div><div id="S8" class="sec"><h3 id="S8title">Statistical analysis</h3><p id="P20" class="p p-first-last">All results are expressed as means &#x000b1; s.e.m. We analyzed the data with unpaired two-tailed <em>t</em> tests (Prism 5).</p></div><div id="S9" class="sec sec-last"><h3 id="S9title">Additional methods</h3><p id="P21" class="p p-first-last">Additional methods are described in the <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Methods</a>.</p></div></div><div id="SM" class="tsec sec"><a id="supplementary-material-sec"></a><h2 class="head no_bottom_margin" id="SMtitle">Supplementary Material</h2><!--/article/body/sec/--><div class="sec suppmat" id="SD1"><h4>1</h4><div class="sup-box half_rhythm" id="d37e661"><a href="/pmc/articles/PMC2834826/bin/NIHMS172047-supplement-1.doc" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(575K, doc)</sup></div></div></div><div id="S10" class="tsec sec"><h2 class="head no_bottom_margin" id="S10title">ACKNOWLEDGMENTS</h2><div class="sec"><p id="__p1">We thank K. Nagashima (Image Analysis Laboratory, SAIC-Frederick, Inc., National Cancer Institute) for help with electron microscopy and J.D. Yoder for initiating cryoelectron microscopy reconstruction. We also thank A. Tislerics and J. Stein for help with manuscript preparation, B. Hartman for graphic arts, and members of the Nabel lab for helpful discussions. We thank R. Seder and D.D. Pinschewer (Department of Pathology and Immunology, University of Geneva) for their kind gift of IFN-&#x003b1;/&#x003b2;R<sup>-/-</sup> mice, A. Ault, J.-P. Todd, A. Zajac, C. Chiedi and D. Gordon for plaque assay and processed animal blood samples, J. Greenhouse for RT-PCR assay, B.W. Finneyfrock, T. Jenkins and A. Dodson for animal sampling and care, K. Foulds, M. Donaldson and M. Roederer for monkey sample procedures, and J. Lee for preparing materials. This research was supported by the Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases, U.S. National Institutes of Health.</p></div></div><div id="idm140119622629728" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140119622629728title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="FN2"><p id="P22" class="p p-first-last">The authors declare that they have no competing financial interests.</p></p></div></div><div id="idm140119624044096" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140119624044096title">REFERENCES</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="R1">1. <span class="element-citation">Simon F, Savini H, Parola P. Chikungunya: a paradigm of emergence and globalization of vector-borne diseases. <span><span class="ref-journal">Med. Clin North Am. </span>2008;<span class="ref-vol">92</span>:1323\xe2\x80\x931343.</span> [<a href="/pubmed/19061754" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Med.+Clin+North+Am&amp;title=Chikungunya:+a+paradigm+of+emergence+and+globalization+of+vector-borne+diseases&amp;author=F+Simon&amp;author=H+Savini&amp;author=P+Parola&amp;volume=92&amp;publication_year=2008&amp;pages=1323-1343&amp;pmid=19061754&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R2">2. <span class="element-citation">Powers AM, Logue CH. Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus. <span><span class="ref-journal">J Gen. Virol. </span>2007;<span class="ref-vol">88</span>:2363\xe2\x80\x932377.</span> [<a href="/pubmed/17698645" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Gen.+Virol&amp;title=Changing+patterns+of+chikungunya+virus:+re-emergence+of+a+zoonotic+arbovirus&amp;author=AM+Powers&amp;author=CH+Logue&amp;volume=88&amp;publication_year=2007&amp;pages=2363-2377&amp;pmid=17698645&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R3">3. <span class="element-citation">Ross RW. The Newala epidemic. III. The virus: isolation, pathogenic properties and relationship to the epidemic. <span><span class="ref-journal">J. Hyg. (Lond. ) </span>1956;<span class="ref-vol">54</span>:177\xe2\x80\x93191.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2218030/">PMC free article</a>]</span> [<a href="/pubmed/13346078" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Hyg.+(Lond.+)&amp;title=The+Newala+epidemic.+III.+The+virus:+isolation,+pathogenic+properties+and+relationship+to+the+epidemic&amp;author=RW+Ross&amp;volume=54&amp;publication_year=1956&amp;pages=177-191&amp;pmid=13346078&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R4">4. <span class="element-citation">Staples JE, Breiman RF, Powers AM. Chikungunya fever: an epidemiological review of a re-emerging infectious disease. <span><span class="ref-journal">Clin Infect. Dis. </span>2009;<span class="ref-vol">49</span>:942\xe2\x80\x93948.</span> [<a href="/pubmed/19663604" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Infect.+Dis&amp;title=Chikungunya+fever:+an+epidemiological+review+of+a+re-emerging+infectious+disease&amp;author=JE+Staples&amp;author=RF+Breiman&amp;author=AM+Powers&amp;volume=49&amp;publication_year=2009&amp;pages=942-948&amp;pmid=19663604&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R5">5. <span class="element-citation">Tsetsarkin KA, Vanlandingham DL, McGee CE, Higgs S. A single mutation in chikungunya virus affects vector specificity and epidemic potential. <span><span class="ref-journal">PLoS. Pathog. </span>2007;<span class="ref-vol">3</span>:e201.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2134949/">PMC free article</a>]</span> [<a href="/pubmed/18069894" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS.+Pathog&amp;title=A+single+mutation+in+chikungunya+virus+affects+vector+specificity+and+epidemic+potential&amp;author=KA+Tsetsarkin&amp;author=DL+Vanlandingham&amp;author=CE+McGee&amp;author=S+Higgs&amp;volume=3&amp;publication_year=2007&amp;pages=e201&amp;pmid=18069894&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R6">6. <span class="element-citation">Enserink M, Entomology A mosquito goes global. <span><span class="ref-journal">Science. </span>2008;<span class="ref-vol">320</span>:864\xe2\x80\x93866.</span> [<a href="/pubmed/18487167" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=A+mosquito+goes+global&amp;author=M+Enserink&amp;author=+Entomology&amp;volume=320&amp;publication_year=2008&amp;pages=864-866&amp;pmid=18487167&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R7">7. <span class="element-citation">Strauss JH, Strauss EG. The alphaviruses: gene expression, replication, and evolution. <span><span class="ref-journal">Microbiol. Rev. </span>1994;<span class="ref-vol">58</span>:491\xe2\x80\x93562.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC372977/">PMC free article</a>]</span> [<a href="/pubmed/7968923" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Microbiol.+Rev&amp;title=The+alphaviruses:+gene+expression,+replication,+and+evolution&amp;author=JH+Strauss&amp;author=EG+Strauss&amp;volume=58&amp;publication_year=1994&amp;pages=491-562&amp;pmid=7968923&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R8">8. <span class="element-citation">Cheng RH, et al.  Nucleocapsid and glycoprotein organization in an enveloped virus. <span><span class="ref-journal">Cell. </span>1995;<span class="ref-vol">80</span>:621\xe2\x80\x93630.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4167723/">PMC free article</a>]</span> [<a href="/pubmed/7867069" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Nucleocapsid+and+glycoprotein+organization+in+an+enveloped+virus&amp;author=RH+Cheng&amp;volume=80&amp;publication_year=1995&amp;pages=621-630&amp;pmid=7867069&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R9">9. <span class="element-citation">Zhang W, et al.  Placement of the structural proteins in Sindbis virus. <span><span class="ref-journal">J Virol. </span>2002;<span class="ref-vol">76</span>:11645\xe2\x80\x9311658.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC136788/">PMC free article</a>]</span> [<a href="/pubmed/12388725" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Placement+of+the+structural+proteins+in+Sindbis+virus&amp;author=W+Zhang&amp;volume=76&amp;publication_year=2002&amp;pages=11645-11658&amp;pmid=12388725&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R10">10. <span class="element-citation">Arankalle VA, et al.  Genetic divergence of Chikungunya viruses in India (1963-2006) with special reference to the 2005-2006 explosive epidemic. <span><span class="ref-journal">J Gen. Virol. </span>2007;<span class="ref-vol">88</span>:1967\xe2\x80\x931976.</span> [<a href="/pubmed/17554030" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Gen.+Virol&amp;title=Genetic+divergence+of+Chikungunya+viruses+in+India+(1963-2006)+with+special+reference+to+the+2005-2006+explosive+epidemic&amp;author=VA+Arankalle&amp;volume=88&amp;publication_year=2007&amp;pages=1967-1976&amp;pmid=17554030&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R11">11. <span class="element-citation">Harrison VR, Binn LN, Randall R. Comparative immunogenicities of chikungunya vaccines prepared in avian and mammalian tissues. <span><span class="ref-journal">Am. J Trop. Med. Hyg. </span>1967;<span class="ref-vol">16</span>:786\xe2\x80\x93791.</span> [<a href="/pubmed/4965219" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am.+J+Trop.+Med.+Hyg&amp;title=Comparative+immunogenicities+of+chikungunya+vaccines+prepared+in+avian+and+mammalian+tissues&amp;author=VR+Harrison&amp;author=LN+Binn&amp;author=R+Randall&amp;volume=16&amp;publication_year=1967&amp;pages=786-791&amp;pmid=4965219&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R12">12. <span class="element-citation">Naldini L, Blomer U, Gage FH, Trono D, Verma IM. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. <span><span class="ref-journal">Proc. Natl. Acad. Sci. USA. </span>1996;<span class="ref-vol">93</span>:11382\xe2\x80\x9311388.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC38066/">PMC free article</a>]</span> [<a href="/pubmed/8876144" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc.+Natl.+Acad.+Sci.+USA&amp;title=Efficient+transfer,+integration,+and+sustained+long-term+expression+of+the+transgene+in+adult+rat+brains+injected+with+a+lentiviral+vector&amp;author=L+Naldini&amp;author=U+Blomer&amp;author=FH+Gage&amp;author=D+Trono&amp;author=IM+Verma&amp;volume=93&amp;publication_year=1996&amp;pages=11382-11388&amp;pmid=8876144&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R13">13. <span class="element-citation">Yang Z-Y, et al.  pH-dependent entry of Severe Acute Respiratory Syndrome coronavirus is mediated by the Spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN. <span><span class="ref-journal">J. Virol. </span>2004;<span class="ref-vol">78</span>:5642\xe2\x80\x935650.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC415834/">PMC free article</a>]</span> [<a href="/pubmed/15140961" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Virol&amp;title=pH-dependent+entry+of+Severe+Acute+Respiratory+Syndrome+coronavirus+is+mediated+by+the+Spike+glycoprotein+and+enhanced+by+dendritic+cell+transfer+through+DC-SIGN&amp;author=Z-Y+Yang&amp;volume=78&amp;publication_year=2004&amp;pages=5642-5650&amp;pmid=15140961&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R14">14. <span class="element-citation">Yang Z-Y, et al.  Immunization by avian H5 influenza hemagglutinin mutants with altered receptor binding specificity. <span><span class="ref-journal">Science. </span>2007;<span class="ref-vol">317</span>:825\xe2\x80\x93828.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2367145/">PMC free article</a>]</span> [<a href="/pubmed/17690300" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Immunization+by+avian+H5+influenza+hemagglutinin+mutants+with+altered+receptor+binding+specificity&amp;author=Z-Y+Yang&amp;volume=317&amp;publication_year=2007&amp;pages=825-828&amp;pmid=17690300&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R15">15. <span class="element-citation">Sourisseau M, et al.  Characterization of reemerging chikungunya virus. <span><span class="ref-journal">PLoS. Pathog. </span>2007;<span class="ref-vol">3</span>:e89.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1904475/">PMC free article</a>]</span> [<a href="/pubmed/17604450" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS.+Pathog&amp;title=Characterization+of+reemerging+chikungunya+virus&amp;author=M+Sourisseau&amp;volume=3&amp;publication_year=2007&amp;pages=e89&amp;pmid=17604450&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R16">16. <span class="element-citation">McClure MO, Sommerfelt MA, Marsh M, Weiss RA. The pH independence of mammalian retrovirus infection. <span><span class="ref-journal">J Gen. Virol. </span>1990;<span class="ref-vol">71</span>(Pt 4):767\xe2\x80\x93773.</span> [<a href="/pubmed/2157795" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Gen.+Virol&amp;title=The+pH+independence+of+mammalian+retrovirus+infection&amp;author=MO+McClure&amp;author=MA+Sommerfelt&amp;author=M+Marsh&amp;author=RA+Weiss&amp;volume=71&amp;issue=Pt+4&amp;publication_year=1990&amp;pages=767-773&amp;pmid=2157795&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R17">17. <span class="element-citation">Eckels KH, Harrison VR, Hetrick FM. Chikungunya virus vaccine prepared by Tween-ether extraction. <span><span class="ref-journal">Appl. Microbiol. </span>1970;<span class="ref-vol">19</span>:321\xe2\x80\x93325.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC376676/">PMC free article</a>]</span> [<a href="/pubmed/4985431" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Appl.+Microbiol&amp;title=Chikungunya+virus+vaccine+prepared+by+Tween-ether+extraction&amp;author=KH+Eckels&amp;author=VR+Harrison&amp;author=FM+Hetrick&amp;volume=19&amp;publication_year=1970&amp;pages=321-325&amp;pmid=4985431&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R18">18. <span class="element-citation">Pletnev SV, et al.  Locations of carbohydrate sites on alphavirus glycoproteins show that E1 forms an icosahedral scaffold. <span><span class="ref-journal">Cell. </span>2001;<span class="ref-vol">105</span>:127\xe2\x80\x93136.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4140091/">PMC free article</a>]</span> [<a href="/pubmed/11301008" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Locations+of+carbohydrate+sites+on+alphavirus+glycoproteins+show+that+E1+forms+an+icosahedral+scaffold&amp;author=SV+Pletnev&amp;volume=105&amp;publication_year=2001&amp;pages=127-136&amp;pmid=11301008&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R19">19. <span class="element-citation">Couderc T, et al.  A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease. <span><span class="ref-journal">PLoS. Pathog. </span>2008;<span class="ref-vol">4</span>:e29.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2242832/">PMC free article</a>]</span> [<a href="/pubmed/18282093" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS.+Pathog&amp;title=A+mouse+model+for+Chikungunya:+young+age+and+inefficient+type-I+interferon+signaling+are+risk+factors+for+severe+disease&amp;author=T+Couderc&amp;volume=4&amp;publication_year=2008&amp;pages=e29&amp;pmid=18282093&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R20">20. <span class="element-citation">Couderc T, et al.  Prophylaxis and therapy for Chikungunya virus infection. <span><span class="ref-journal">J Infect. Dis. </span>2009;<span class="ref-vol">200</span>:516\xe2\x80\x93523.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7109959/">PMC free article</a>]</span> [<a href="/pubmed/19572805" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Infect.+Dis&amp;title=Prophylaxis+and+therapy+for+Chikungunya+virus+infection&amp;author=T+Couderc&amp;volume=200&amp;publication_year=2009&amp;pages=516-523&amp;pmid=19572805&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R21">21. <span class="element-citation">Levitt NH, et al.  Development of an attenuated strain of chikungunya virus for use in vaccine production. <span><span class="ref-journal">Vaccine. </span>1986;<span class="ref-vol">4</span>:157\xe2\x80\x93162.</span> [<a href="/pubmed/3020820" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Development+of+an+attenuated+strain+of+chikungunya+virus+for+use+in+vaccine+production&amp;author=NH+Levitt&amp;volume=4&amp;publication_year=1986&amp;pages=157-162&amp;pmid=3020820&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R22">22. <span class="element-citation">McClain DJ, et al.  Immunologic interference from sequential administration of live attenuated alphavirus vaccines. <span><span class="ref-journal">J Infect. Dis. </span>1998;<span class="ref-vol">177</span>:634\xe2\x80\x93641.</span> [<a href="/pubmed/9498442" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Infect.+Dis&amp;title=Immunologic+interference+from+sequential+administration+of+live+attenuated+alphavirus+vaccines&amp;author=DJ+McClain&amp;volume=177&amp;publication_year=1998&amp;pages=634-641&amp;pmid=9498442&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R23">23. <span class="element-citation">Edelman R, et al.  Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218. <span><span class="ref-journal">Am. J Trop. Med. Hyg. </span>2000;<span class="ref-vol">62</span>:681\xe2\x80\x93685.</span> [<a href="/pubmed/11304054" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am.+J+Trop.+Med.+Hyg&amp;title=Phase+II+safety+and+immunogenicity+study+of+live+chikungunya+virus+vaccine+TSI-GSD-218&amp;author=R+Edelman&amp;volume=62&amp;publication_year=2000&amp;pages=681-685&amp;pmid=11304054&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R24">24. <span class="element-citation">Harrison VR, Eckels KH, Bartelloni PJ, Hampton C. Production and evaluation of a formalin-killed Chikungunya vaccine. <span><span class="ref-journal">J Immunol. </span>1971;<span class="ref-vol">107</span>:643\xe2\x80\x93647.</span> [<a href="/pubmed/4999088" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=Production+and+evaluation+of+a+formalin-killed+Chikungunya+vaccine&amp;author=VR+Harrison&amp;author=KH+Eckels&amp;author=PJ+Bartelloni&amp;author=C+Hampton&amp;volume=107&amp;publication_year=1971&amp;pages=643-647&amp;pmid=4999088&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R25">25. <span class="element-citation">Tiwari M, et al.  Assessment of immunogenic potential of Vero adapted formalin inactivated vaccine derived from novel ECSA genotype of Chikungunya virus. <span><span class="ref-journal">Vaccine. </span>2009;<span class="ref-vol">27</span>:2513\xe2\x80\x932522.</span> [<a href="/pubmed/19368794" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Assessment+of+immunogenic+potential+of+Vero+adapted+formalin+inactivated+vaccine+derived+from+novel+ECSA+genotype+of+Chikungunya+virus&amp;author=M+Tiwari&amp;volume=27&amp;publication_year=2009&amp;pages=2513-2522&amp;pmid=19368794&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R26">26. <span class="element-citation">Wang E, et al.  Chimeric alphavirus vaccine candidates for chikungunya. <span><span class="ref-journal">Vaccine. </span>2008;<span class="ref-vol">26</span>:5030\xe2\x80\x935039.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2571998/">PMC free article</a>]</span> [<a href="/pubmed/18692107" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Chimeric+alphavirus+vaccine+candidates+for+chikungunya&amp;author=E+Wang&amp;volume=26&amp;publication_year=2008&amp;pages=5030-5039&amp;pmid=18692107&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R27">27. <span class="element-citation">Muthumani K, et al.  Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus. <span><span class="ref-journal">Vaccine. </span>2008;<span class="ref-vol">26</span>:5128\xe2\x80\x935134.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2582145/">PMC free article</a>]</span> [<a href="/pubmed/18471943" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Immunogenicity+of+novel+consensus-based+DNA+vaccines+against+Chikungunya+virus&amp;author=K+Muthumani&amp;volume=26&amp;publication_year=2008&amp;pages=5128-5134&amp;pmid=18471943&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R28">28. <span class="element-citation">Chackerian B. Virus-like particles: flexible platforms for vaccine development. <span><span class="ref-journal">Expert. Rev. Vaccines. </span>2007;<span class="ref-vol">6</span>:381\xe2\x80\x93390.</span> [<a href="/pubmed/17542753" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Expert.+Rev.+Vaccines&amp;title=Virus-like+particles:+flexible+platforms+for+vaccine+development&amp;author=B+Chackerian&amp;volume=6&amp;publication_year=2007&amp;pages=381-390&amp;pmid=17542753&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R29">29. <span class="element-citation">Bachmann MF, et al.  The influence of antigen organization on B cell responsiveness. <span><span class="ref-journal">Science. </span>1993;<span class="ref-vol">262</span>:1448\xe2\x80\x931451.</span> [<a href="/pubmed/8248784" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=The+influence+of+antigen+organization+on+B+cell+responsiveness&amp;author=MF+Bachmann&amp;volume=262&amp;publication_year=1993&amp;pages=1448-1451&amp;pmid=8248784&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R30">30. <span class="element-citation">Noad R, Roy P. Virus-like particles as immunogens. <span><span class="ref-journal">Trends Microbiol. </span>2003;<span class="ref-vol">11</span>:438\xe2\x80\x93444.</span> [<a href="/pubmed/13678860" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Trends+Microbiol&amp;title=Virus-like+particles+as+immunogens&amp;author=R+Noad&amp;author=P+Roy&amp;volume=11&amp;publication_year=2003&amp;pages=438-444&amp;pmid=13678860&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R31">31. <span class="element-citation">Ludwig C, Wagner R. Virus-like particles-universal molecular toolboxes. <span><span class="ref-journal">Curr. Opin. Biotechnol. </span>2007;<span class="ref-vol">18</span>:537\xe2\x80\x93545.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7126091/">PMC free article</a>]</span> [<a href="/pubmed/18083549" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr.+Opin.+Biotechnol&amp;title=Virus-like+particles-universal+molecular+toolboxes&amp;author=C+Ludwig&amp;author=R+Wagner&amp;volume=18&amp;publication_year=2007&amp;pages=537-545&amp;pmid=18083549&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R32">32. <span class="element-citation">Akahata W, Yang ZY, Nabel GJ. Comparative immunogenicity of human immunodeficiency virus particles and corresponding polypeptides in a DNA vaccine. <span><span class="ref-journal">J. Virol. </span>2005;<span class="ref-vol">79</span>:626\xe2\x80\x93631.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC538686/">PMC free article</a>]</span> [<a href="/pubmed/15596858" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Virol&amp;title=Comparative+immunogenicity+of+human+immunodeficiency+virus+particles+and+corresponding+polypeptides+in+a+DNA+vaccine&amp;author=W+Akahata&amp;author=ZY+Yang&amp;author=GJ+Nabel&amp;volume=79&amp;publication_year=2005&amp;pages=626-631&amp;pmid=15596858&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R33">33. <span class="element-citation">Tang G, et al.  EMAN2: an extensible image processing suite for electron microscopy. <span><span class="ref-journal">J Struct. Biol. </span>2007;<span class="ref-vol">157</span>:38\xe2\x80\x9346.</span> [<a href="/pubmed/16859925" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Struct.+Biol&amp;title=EMAN2:+an+extensible+image+processing+suite+for+electron+microscopy&amp;author=G+Tang&amp;volume=157&amp;publication_year=2007&amp;pages=38-46&amp;pmid=16859925&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R34">34. <span class="element-citation">Ludtke SJ, Baldwin PR, Chiu W. EMAN: semiautomated software for high-resolution single-particle reconstructions. <span><span class="ref-journal">J Struct. Biol. </span>1999;<span class="ref-vol">128</span>:82\xe2\x80\x9397.</span> [<a href="/pubmed/10600563" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Struct.+Biol&amp;title=EMAN:+semiautomated+software+for+high-resolution+single-particle+reconstructions&amp;author=SJ+Ludtke&amp;author=PR+Baldwin&amp;author=W+Chiu&amp;volume=128&amp;publication_year=1999&amp;pages=82-97&amp;pmid=10600563&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2834826&amp;issue-id=185483&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--></div>\n            \n            \n        \n            \n        </div>\n        <!-- Book content -->\n    </div>\n    \n    <div id="rightcolumn" class="four_col col last">\n        <!-- Custom content above discovery portlets -->\n        <div class="col6">\n            \n        </div>\n        \n        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC2834826/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC2834826/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC2834826/pdf/nihms-172047.pdf">PDF (743K)</a></li> | <li><a href="#" data-citationid="PMC2834826" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2834826%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />\n                             Facebook\n                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2834826%2F&amp;text=A%20VLP%20vaccine%20for%20epidemic%20Chikungunya%20virus%20protects%20non-human%20primates%20against%20infection"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />\n                             Twitter\n                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2834826%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />\n                             Google+\n                        </a></li></ul></div>\n        \n        <div id="ajax-portlets" data-pmid="20111039" data-aiid="2834826" data-aid="2834826" data-iid="185483" data-domainid="319" data-domain="nihpa" data-accid="PMC2834826" data-md5="4f1f3aee64ec65a2e1a1b2dbc93fcb1d"></div>\n                \n        <!-- Custom content below discovery portlets -->\n        <div class="col7">\n            \n        </div>\n    </div>\n</div>\n\n<!-- Custom content after all -->\n<div class="col8">\n    \n</div>\n<div class="col9">\n    \n</div>\n\n<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>\n<script>\n    (function($){\n        $(\'.skiplink\').each(function(i, item){\n            var href = $($(item).attr(\'href\'));\n            href.attr(\'tabindex\', \'-1\').addClass(\'skiptarget\'); // ensure the target can receive focus\n            $(item).on(\'click\', function(event){\n                event.preventDefault();\n                $.scrollTo(href, 0, {\n                    onAfter: function(){\n                        href.focus();\n                    }\n                });\n            });\n        });\n    })(jQuery);\n</script>\n\n\n\n<div id="body-link-poppers"></div>\n                        </div>\n                        <div class="bottom">\n                            \n                            <div id="NCBIFooter_dynamic">\n    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>\n    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2020-04-17T20:33:44-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc102&amp;ncbi_phid=8A1BC6A5E9A463610000000002CB02CB&amp;ncbi_session=8A1BC6A5E9A4AE71_0715SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2834826%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>\n    \n</div>\n\n                            <div class="footer" id="footer">\n    \n    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>\n    <div id="external-disclaimer" class="offscreen_noflow">\n        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.\n    </div>    \n    <div id="ncbifooter" class="contact_info">      \n        <div id="footer-contents-right">\n            <div id="nlm_thumb_logo">\n                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>\n            </div>\n            <div id="nih_thumb_logo">\n                <a href="https://www.nih.gov" title="NIH">NIH</a>\n            </div>\n            <div id="hhs_thumb_logo">\n                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>\n            </div>\n            <div id="usagov_thumb_logo">\n                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>\n            </div>         \n        </div>\n        \n        <div id="footer-contents-left">\n            <p class="address vcard">\n                <span class="url">\n                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for\n                        Biotechnology Information</a>,\n                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>\n                <span class="adr">\n                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>\n                    <span class="region">MD</span>, <span class="postal-code">20894</span>\n                    <span class="country-name">USA</span>\n                </span>\n            </p>\n            \n            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>\n        </div>\n    </div>\n    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    \n    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>\n</div>\n                        </div>\n                    </div>\n                    <!--/.page-->\n                </div>\n                <!--/.wrap-->\n            </div><!-- /.twelve_col -->\n        </div>\n        <!-- /.grid -->\n\n        <span class="PAFAppResources"></span>\n        \n        <!-- BESelector tab -->\n        \n        \n        \n        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=nihpa&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC2834826/&amp;ncbi_app=pmc" /></noscript>\n        \n        \n        <!-- usually for JS scripts at page bottom -->\n        <!--<component id="PageFixtures" label="styles"></component>-->\n    \n\n<!-- 8A1BC6A5E9A4AE71_0715SID /projects/PMC/PMCViewer@4.46 ptpmc102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->\n\n<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>\n</html>'